Drugs Made In America Acquisition Corp.

DMAA

Exchange: Nasdaq
Industry: Blank Checks
SEC CIK: 0002028614

SEC filings (opens in a new tab)

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.

Other share classesDMAAR DMAAU

Q1 2025 vs. Q4 2024

How the institutions holding Drugs Made In America Acquisition Corp. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of DMAA: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Q1 2025	Change
Holders	0	24	+24
Shares	0	19.7M	+19.7M
Value	$0	$171.3M	+$171.3M

New holders (24)

Institutions that held Drugs Made In America Acquisition Corp. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to DMAA in Q1 2025
Institution	Shares	Value	% of portfolio
Karpus Management, Inc.	2,324,034	$23.3M	0.75%
Vivaldi Asset Management, LLC	2,066,702	$20.7M	1.50%
Polar Asset Management Partners Inc.	1,900,000	$19.0M	0.63%
Glazer Capital, LLC	1,822,952	$18.3M	0.85%
Hudson Bay Capital Management LP	1,800,000	$18.0M	0.11%
Westchester Capital Management, LLC	979,000	$9.81M	0.57%
Aristeia Capital LLC	900,000	$9.02M	0.28%
Quarry LP	650,000	$6.51M	1.68%
Wolverine Asset Management LLC	603,038	$6.04M	0.12%
Atw Spac Management LLC	570,000	$5.71M	9.53%
Mizuho Securities USA LLC	542,962	$5.40M	0.12%
LMR Partners LLP	500,000	$5.01M	0.10%
Whitebox Advisors LLC	400,000	$4.01M	0.13%
CNH Partners LLC	380,314	$3.81M	0.09%
Mangrove Partners	350,000	$3.51M	0.40%
DLD Asset Management, LP	350,000	$3.51M	0.51%
Toronto Dominion Bank	2,210,100	$3.47M	0.01%
Schonfeld Strategic Advisors LLC	200,000	$2.00M	0.01%
Crossingbridge Advisors, LLC	850,000	$1.30M	0.69%
Goldman Sachs Group Inc	119,686	$1.20M	0.00%
Warberg Asset Management LLC	92,055	$922.4K	0.25%
Geode Capital Management, LLC	45,462	$455.5K	0.00%
Virtu Financial LLC	31,777	$318.0K	0.02%
Morgan Stanley	20	$200	0.00%

Sold out (0)

Institutions that held Drugs Made In America Acquisition Corp. at the end of Q4 2024 and filed for Q1 2025 without it.

None.